WSE:POM

Stock Analysis Report

Executive Summary

Polmed S.A. provides medical services to private and institutional clients.

Snowflake

Fundamentals

Flawless balance sheet with solid track record.

Share Price & News

How has Polmed's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

POM

-0.5%

PL Healthcare

0.02%

PL Market


1 Year Return

16.5%

POM

33.6%

PL Healthcare

-3.3%

PL Market


Shareholder returns

POMIndustryMarket
7 Day0%-0.5%0.02%
30 Day0%0.06%-2.5%
90 Day-0.7%11.8%-7.4%
1 Year16.5%16.5%36.1%33.6%-0.4%-3.3%
3 Year11.3%1.4%9.3%3.4%11.3%3.4%
5 Year27.5%11.5%59.8%49.0%-1.0%-13.0%

Price Volatility Vs. Market

How volatile is Polmed's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Polmed undervalued compared to its fair value and its price relative to the market?

9.27x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Information is not available.

Information is not available.


Price To Earnings Ratio

Information is not available.

Information is not available.


Price to Earnings Growth Ratio

Information is not available.


Price to Book Ratio

Information is not available.


Next Steps

Future Growth

How is Polmed forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

5.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Information is not available.

Information is not available.

High Growth Earnings: POM's earnings are forecast to grow, but not significantly.

Information is not available.

Information is not available.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has Polmed performed over the past 5 years?

27.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Information is not available.

Information is not available.

Information is not available.


Return on Equity

Information is not available.


Return on Assets

Information is not available.


Return on Capital Employed

Information is not available.


Next Steps

Financial Health

How is Polmed's financial position?


Financial Position Analysis

Information is not available.

Information is not available.


Debt to Equity History and Analysis

Information is not available.

Information is not available.

Information is not available.

Information is not available.


Balance Sheet

Information is not available.

Information is not available.


Next Steps

Dividend

What is Polmed's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

company0%marketbottom25%2.7%markettop25%7.4%industryaverage1.8%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Information is not available.

Information is not available.

Stable Dividend: Insufficient data to determine if POM's dividends per share have been stable in the past.

Information is not available.


Current Payout to Shareholders

Information is not available.


Future Payout to Shareholders

Information is not available.


Next Steps

Management

What is the CEO of Polmed's salary, the management and board of directors tenure and is there insider trading?

zł479k

CEO Compensation


CEO

Radoslaw Szubert 0

0yrs

Tenure

zł479,000

Compensation

Mr. Radosaw Szubert serves as the Chairman of the Board at Polmed S.A. 


Insider Trading

Information is not available.


Ownership Breakdown


Management Team

  • Radoslaw Szubert

    Chairman of the Board

    • Tenure: 0yrs
    • Compensation: zł479.00k
  • Romuald Magdon

    Vice President of the Board of Directors

    • Tenure: 0yrs
    • Compensation: zł479.00k
  • Katarzyna Plit-Muszynska

    Sales Director

    • Tenure: 0yrs
  • Alicja Czechowska

    Financial Director

    • Tenure: 0yrs
  • Grazyna Fijal

    Staff Director

    • Tenure: 0yrs
  • Grazyna Jendyk

    Manager of the Board of Directors Office

    • Tenure: 0yrs
  • Dorota Cerowska

    Chief Accountant

    • Tenure: 0yrs

Board Members

  • Krzysztof Plachta (59yo)

    Chairperson of the Supervisory Board

    • Tenure: 0yrs
    • Compensation: zł5.00k
  • Robert Bozyk

    Vice Chairperson of the Supervisory Board

    • Tenure: 0yrs
  • Monika Gaszewska

    Vice President of the Supervisory Board

    • Tenure: 0yrs
    • Compensation: zł4.00k
  • Tomasz Polakowski

    Member of Supervisory Board

    • Tenure: 0yrs
    • Compensation: zł3.00k
  • Boleslaw Rutkowski

    Member of the Supervisory Board

    • Tenure: 0yrs
  • Jacek Dudkiewicz

    Member of Supervisory Board

    • Tenure: 0yrs
    • Compensation: zł4.00k

Company Information

Polmed S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Polmed S.A.
  • Ticker: POM
  • Exchange: WSE
  • Founded: 1999
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: zł46.654m
  • Shares outstanding: 16.09m
  • Website: https://www.polmed.pl

Number of Employees


Location

  • Polmed S.A.
  • Os.Kopernika 21
  • Starogard Gdanski
  • 83-200
  • Poland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
POMWSE (Warsaw Stock Exchange)YesCommon Bearer SharesPLPLNDec 2010
0Q3OLSE (London Stock Exchange)YesCommon Bearer SharesGBPLNDec 2010

Biography

Polmed S.A. provides medical services to private and institutional clients. The company offers services, including basic and specialist medical care, full medical diagnostics, rehabilitation, dentistry, ae ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2018/11/27 19:06
End of Day Share Price2018/09/21 00:00
Earnings2018/06/30
Annual Earnings2017/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.